1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. HOLOGIC, INC.
Hologic, Inc.
XNAS: HOLX
Momentum Trap
Download real time
76.01 0.36 (0.48%)
New 52W High today
101.9M
XNAS Volume
High volume today

XNAS 06 Apr, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for Hologic

The latest disclosure was made by Anne M. Liddy in Hologic where a trade of 185 Common Stock done at an average price of $75.4 was reported to US exchanges on Feb. 27, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Anne M. Liddy General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.36 per share. 27 Feb 2026 185 28,052 (0%) 0% 75.4 13,942 Common Stock
Charles J. Dockendorff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2026 3,190 6,626 (0%) 0% - Common Stock
Martin D. Madaus Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2026 3,190 5,396 (0%) 0% - Common Stock
Amy A. Wendell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2026 3,190 25,784 (0%) 0% - Common Stock
Stacey D. Stewart Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2026 3,190 8,358 (0%) 0% - Common Stock
Ludwig N. Hantson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2026 3,190 16,146 (0%) 0% - Common Stock
Christiana Stamoulis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2026 3,190 50,526 (0%) 0% - Common Stock
Wayde D. McMillan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2026 3,190 4,932 (0%) 0% - Common Stock
Nanaz Mohtashami Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2026 3,190 7,371 (0%) 0% - Common Stock
Mark Horvath President, Breast & Skeletal Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.15 per share. 10 Feb 2026 113 23,026 (0%) 0% 75.2 8,492 Common Stock
Diana De Walt SVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.93 per share. 30 Jan 2026 4,416 7,603 (0%) 0% 74.9 330,891 Common Stock
Brandon Schnittker President, GYN Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.00 per share. 12 Dec 2025 90 17,512 (0%) 0% 75 6,750 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.15 per share. 14 Nov 2025 6,874 1,423,837 (0%) 0% 74.1 509,707 Common Stock
Karleen M. Oberton Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.15 per share. 14 Nov 2025 1,333 150,735 (0%) 0% 74.2 98,842 Common Stock
Benjamin J. Cohn Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.15 per share. 14 Nov 2025 187 17,884 (0%) 0% 74.1 13,866 Common Stock
Essex D. Mitchell Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.15 per share. 14 Nov 2025 1,342 77,610 (0%) 0% 74.1 99,509 Common Stock
Jan Verstreken Group President, International Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.15 per share. 14 Nov 2025 196 134,039 (0%) 0% 74.1 14,533 Common Stock
Jennifer Schneiders President, Diag. Solutions Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.15 per share. 14 Nov 2025 561 41,318 (0%) 0% 74.1 41,598 Common Stock
Brandon Schnittker President, GYN Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.15 per share. 14 Nov 2025 178 17,602 (0%) 0% 74.2 13,199 Common Stock
Anne M. Liddy General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.15 per share. 14 Nov 2025 337 28,237 (0%) 0% 74.2 24,989 Common Stock
Mark Horvath President, Breast & Skeletal Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Nov 2025 13,458 23,139 (0%) 0% - Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.60 per share. 07 Nov 2025 6,679 1,430,711 (0%) 0% 74.6 498,253 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2025 169,582 1,437,390 (0%) 0% - Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.10 per share. 07 Nov 2025 50,405 1,267,808 (0%) 0% 74.1 3,735,011 Common Stock
Karleen M. Oberton Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.60 per share. 07 Nov 2025 1,449 152,068 (0%) 0% 74.6 108,095 Common Stock
Karleen M. Oberton Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.10 per share. 07 Nov 2025 9,427 109,776 (0%) 0% 74.1 698,541 Common Stock
Karleen M. Oberton Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2025 43,741 153,517 (0%) 0% - Common Stock
Benjamin J. Cohn Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.60 per share. 07 Nov 2025 181 18,071 (0%) 0% 74.6 13,503 Common Stock
Benjamin J. Cohn Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2025 5,047 18,252 (0%) 0% - Common Stock
Benjamin J. Cohn Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.10 per share. 07 Nov 2025 1,078 13,205 (0%) 0% 74.1 79,880 Common Stock
Essex D. Mitchell Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.10 per share. 07 Nov 2025 3,927 33,547 (0%) 0% 74.1 290,991 Common Stock
Essex D. Mitchell Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.60 per share. 07 Nov 2025 1,701 78,952 (0%) 0% 74.6 126,895 Common Stock
Essex D. Mitchell Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2025 47,106 80,653 (0%) 0% - Common Stock
Jan Verstreken Group President, International Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.60 per share. 07 Nov 2025 178 134,235 (0%) 0% 74.6 13,279 Common Stock
Jan Verstreken Group President, International Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2025 16,823 134,413 (0%) 0% - Common Stock
Jan Verstreken Group President, International Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.10 per share. 07 Nov 2025 1,420 117,590 (0%) 0% 74.1 105,222 Common Stock
Jennifer Schneiders President, Diag. Solutions Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.10 per share. 07 Nov 2025 158 12,299 (0%) 0% 74.1 11,708 Common Stock
Jennifer Schneiders President, Diag. Solutions Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.60 per share. 07 Nov 2025 702 41,879 (0%) 0% 74.6 52,369 Common Stock
Jennifer Schneiders President, Diag. Solutions Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2025 30,282 42,581 (0%) 0% - Common Stock
Brandon Schnittker President, GYN Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.10 per share. 07 Nov 2025 138 5,956 (0%) 0% 74.1 10,226 Common Stock
Brandon Schnittker President, GYN Surgical Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2025 12,113 18,069 (0%) 0% - Common Stock
Brandon Schnittker President, GYN Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.60 per share. 07 Nov 2025 289 17,780 (0%) 0% 74.6 21,559 Common Stock
Anne M. Liddy General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2025 17,496 28,980 (0%) 0% - Common Stock
Anne M. Liddy General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.60 per share. 07 Nov 2025 406 28,574 (0%) 0% 74.6 30,288 Common Stock
Anne M. Liddy General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.10 per share. 07 Nov 2025 288 11,484 (0%) 0% 74.1 21,341 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2025 83,589 1,318,213 (0%) 0% - Common Stock
Karleen M. Oberton Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2025 17,095 119,203 (0%) 0% - Common Stock
Benjamin J. Cohn Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2025 2,656 14,283 (0%) 0% - Common Stock
Essex D. Mitchell Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2025 9,116 37,474 (0%) 0% - Common Stock
Jan Verstreken Group President, International Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2025 15,196 119,010 (0%) 0% - Common Stock
Mark Horvath President, Breast & Skeletal Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2025 2,278 9,681 (0%) 0% - Common Stock
Christiana Stamoulis Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.04 per share. 20 Oct 2025 7,402 54,738 (0%) 0% 36.0 266,768 Common Stock
Christiana Stamoulis Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Oct 2025 7,402 0 - - Non-qualified Stock Option (Right to Buy)
Christiana Stamoulis Director Sale of securities on an exchange or to another person at price $ 73.07 per share. 20 Oct 2025 7,402 47,336 (0%) 0% 73.1 540,864 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Sep 2025 138,358 0 - - Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan Director, Chairman, President and CEO Sale of securities on an exchange or to another person at price $ 66.13 per share. 22 Sep 2025 22,240 1,350,742 (0%) 0% 66.1 1,470,731 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.96 per share. 22 Sep 2025 138,358 1,372,982 (0%) 0% 40.0 5,528,786 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Sale of securities on an exchange or to another person at price $ 67.32 per share. 22 Sep 2025 38,700 1,234,624 (0%) 0% 67.3 2,605,284 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Sale of securities on an exchange or to another person at price $ 67.04 per share. 22 Sep 2025 77,418 1,273,324 (0%) 0% 67.0 5,190,103 Common Stock
Brandon Schnittker Div. President, GYN Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.17 per share. 30 May 2025 69 6,094 (0%) 0% 62.2 4,290 Common Stock
Martin D. Madaus Director Purchase of securities on an exchange or from another person at price $ 55.24 per share. 07 May 2025 5,445 5,445 (0%) 0% 55.2 300,760 Common Stock
Wayde D. McMillan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2025 5,171 5,171 - - Non-qualified Stock Option (Right to Buy)
Wayde D. McMillan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2025 1,742 1,742 (0%) 0% - Common Stock
Charles J. Dockendorff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 5,535 5,535 - - Non-qualified Stock Option (Right to Buy)
Charles J. Dockendorff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 1,864 3,436 (0%) 0% - Common Stock
Martin D. Madaus Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 1,864 2,206 (0%) 0% - Common Stock
Martin D. Madaus Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 5,535 5,535 - - Non-qualified Stock Option (Right to Buy)
Amy A. Wendell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 5,535 5,535 - - Non-qualified Stock Option (Right to Buy)
Amy A. Wendell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 1,864 22,594 (0%) 0% - Common Stock
Stacey D. Stewart Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 5,535 5,535 - - Non-qualified Stock Option (Right to Buy)
Stacey D. Stewart Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 1,864 5,168 (0%) 0% - Common Stock
Ludwig N. Hantson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 1,864 12,956 (0%) 0% - Common Stock
Ludwig N. Hantson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 5,535 5,535 - - Non-qualified Stock Option (Right to Buy)
Christiana Stamoulis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 5,535 5,535 - - Non-qualified Stock Option (Right to Buy)
Christiana Stamoulis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 1,864 47,336 (0%) 0% - Common Stock
Nanaz Mohtashami Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 5,535 5,535 - - Non-qualified Stock Option (Right to Buy)
Nanaz Mohtashami Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 1,864 4,181 (0%) 0% - Common Stock
Mark Horvath Div. Pres., Breast & Skeletal Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2025 958 7,057 (0%) 0% - Common Stock
Mark Horvath Div. Pres., Breast & Skeletal Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2025 2,844 2,844 - - Non-qualified Stock Option (Right to Buy)
Brandon Schnittker Div. President, GYN Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.66 per share. 13 Dec 2024 90 6,163 (0%) 0% 73.7 6,629 Common Stock
Martin D. Madaus Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 342 342 (0%) 0% - Common Stock
Essex D. Mitchell Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Dec 2024 4,526 0 - - Non-qualified Stock Option (Right to Buy)
Essex D. Mitchell Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Dec 2024 1,956 0 - - Non-qualified Stock Option (Right to Buy)
Essex D. Mitchell Chief Operating Officer Sale of securities on an exchange or to another person at price $ 76.34 per share. 04 Dec 2024 24,856 27,957 (0%) 0% 76.3 1,897,482 Common Stock
Essex D. Mitchell Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.13 per share. 04 Dec 2024 8,915 52,813 (0%) 0% 71.1 634,124 Common Stock
Essex D. Mitchell Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.35 per share. 04 Dec 2024 7,505 43,898 (0%) 0% 68.4 512,967 Common Stock
Essex D. Mitchell Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.97 per share. 04 Dec 2024 1,956 31,867 (0%) 0% 41.0 80,137 Common Stock
Essex D. Mitchell Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.61 per share. 04 Dec 2024 4,526 36,393 (0%) 0% 45.6 206,431 Common Stock
Essex D. Mitchell Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Dec 2024 8,915 2,972 - - Non-qualified Stock Option (Right to Buy)
Essex D. Mitchell Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Dec 2024 7,505 0 - - Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.54 per share. 14 Nov 2024 6,860 1,234,278 (0%) 0% 77.5 531,924 Common Stock
Karleen M. Oberton Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.54 per share. 14 Nov 2024 1,332 102,108 (0%) 0% 77.5 103,283 Common Stock
John M. Griffin General Counsel 14 Nov 2024 1,120 182,514 (0%) 0% 77.5 86,845 Common Stock
Benjamin J. Cohn Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.54 per share. 14 Nov 2024 110 11,250 (0%) 0% 77.5 8,529 Common Stock
Essex D. Mitchell Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.54 per share. 14 Nov 2024 1,341 29,911 (0%) 0% 77.5 103,981 Common Stock
Erik Anderson Div. Pres., Breast & Skeletal Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.54 per share. 14 Nov 2024 390 23,231 (0%) 0% 77.5 30,241 Common Stock
Jan Verstreken Group President, International Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.54 per share. 14 Nov 2024 630 103,814 (0%) 0% 77.5 48,850 Common Stock
Jennifer Schneiders President, Diag. Solutions Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.54 per share. 14 Nov 2024 507 12,096 (0%) 0% 77.5 39,313 Common Stock
Brandon Schnittker Div. President, GYN Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.54 per share. 14 Nov 2024 178 6,253 (0%) 0% 77.5 13,802 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2024 39,677 1,241,138 (0%) 0% - Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.29 per share. 07 Nov 2024 6,214 1,269,908 (0%) 0% 79.3 492,708 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.76 per share. 07 Nov 2024 68,447 1,201,461 (0%) 0% 78.8 5,390,886 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2024 117,801 117,801 - - Non-qualified Stock Option (Right to Buy)
Karleen M. Oberton Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2024 28,047 28,047 - - Non-qualified Stock Option (Right to Buy)
Karleen M. Oberton Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.29 per share. 07 Nov 2024 1,161 106,591 (0%) 0% 79.3 92,056 Common Stock
Karleen M. Oberton Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.76 per share. 07 Nov 2024 12,598 93,993 (0%) 0% 78.8 992,218 Common Stock
Karleen M. Oberton Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2024 9,447 103,440 (0%) 0% - Common Stock
John M. Griffin General Counsel 07 Nov 2024 592 186,635 (0%) 0% 79.3 46,940 Common Stock
John M. Griffin General Counsel 07 Nov 2024 9,299 177,336 (0%) 0% 78.8 732,389 Common Stock
John M. Griffin General Counsel 07 Nov 2024 6,298 183,634 (0%) 0% - Common Stock
John M. Griffin General Counsel 07 Nov 2024 18,698 18,698 - - Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.76 per share. 07 Nov 2024 190 10,180 (0%) 0% 78.8 14,964 Common Stock
Benjamin J. Cohn Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2024 3,505 3,505 - - Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.29 per share. 07 Nov 2024 106 10,370 (0%) 0% 79.3 8,405 Common Stock
Benjamin J. Cohn Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2024 1,180 11,360 (0%) 0% - Common Stock
Essex D. Mitchell Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.29 per share. 07 Nov 2024 422 24,614 (0%) 0% 79.3 33,460 Common Stock
Essex D. Mitchell Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2024 32,722 32,722 - - Non-qualified Stock Option (Right to Buy)
Essex D. Mitchell Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2024 11,021 31,252 (0%) 0% - Common Stock
Essex D. Mitchell Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.76 per share. 07 Nov 2024 4,383 20,231 (0%) 0% 78.8 345,205 Common Stock
Erik Anderson Div. Pres., Breast & Skeletal Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.29 per share. 07 Nov 2024 344 20,295 (0%) 0% 79.3 27,276 Common Stock
Erik Anderson Div. Pres., Breast & Skeletal Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2024 14,023 14,023 - - Non-qualified Stock Option (Right to Buy)
Erik Anderson Div. Pres., Breast & Skeletal Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2024 4,723 23,621 (0%) 0% - Common Stock
Erik Anderson Div. Pres., Breast & Skeletal Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.76 per share. 07 Nov 2024 1,397 18,898 (0%) 0% 78.8 110,028 Common Stock
Jan Verstreken Group President, International Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2024 18,698 18,698 - - Non-qualified Stock Option (Right to Buy)
Jan Verstreken Group President, International Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2024 6,298 104,444 (0%) 0% - Common Stock
Jan Verstreken Group President, International Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.76 per share. 07 Nov 2024 4,928 98,146 (0%) 0% 78.8 388,129 Common Stock
Jan Verstreken Group President, International Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.29 per share. 07 Nov 2024 601 103,074 (0%) 0% 79.3 47,653 Common Stock
Jennifer Schneiders President, Diag. Solutions Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.29 per share. 07 Nov 2024 157 6,430 (0%) 0% 79.3 12,449 Common Stock
Jennifer Schneiders President, Diag. Solutions Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.76 per share. 07 Nov 2024 125 6,305 (0%) 0% 78.8 9,845 Common Stock
Jennifer Schneiders President, Diag. Solutions Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2024 6,298 12,603 (0%) 0% - Common Stock
Jennifer Schneiders President, Diag. Solutions Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2024 18,698 18,698 - - Non-qualified Stock Option (Right to Buy)
Brandon Schnittker Div. President, GYN Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.29 per share. 07 Nov 2024 138 3,597 (0%) 0% 79.3 10,942 Common Stock
Brandon Schnittker Div. President, GYN Surgical Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2024 2,834 6,431 (0%) 0% - Common Stock
Brandon Schnittker Div. President, GYN Surgical Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2024 8,414 8,414 - - Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Nov 2024 118,560 1,276,122 (0%) 0% - Common Stock
Karleen M. Oberton Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Nov 2024 23,710 107,752 (0%) 0% - Common Stock
John M. Griffin General Counsel 05 Nov 2024 20,746 187,227 (0%) 0% - Common Stock
Essex D. Mitchell Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Nov 2024 11,854 25,036 (0%) 0% - Common Stock
Erik Anderson Div. Pres., Breast & Skeletal Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Nov 2024 4,149 20,639 (0%) 0% - Common Stock
Jan Verstreken Group President, International Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Nov 2024 17,780 103,675 (0%) 0% - Common Stock
Karleen M. Oberton Chief Financial Officer Sale of securities on an exchange or to another person at price $ 80.56 per share. 29 Aug 2024 52,679 84,042 (0%) 0% 80.6 4,243,662 Common Stock
Karleen M. Oberton Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Aug 2024 6,725 0 - - Non-qualified Stock Option (Right to Buy)
Karleen M. Oberton Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Aug 2024 26,080 0 - - Non-qualified Stock Option (Right to Buy)
Karleen M. Oberton Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.85 per share. 29 Aug 2024 6,725 136,721 (0%) 0% 40.8 274,716 Common Stock
Karleen M. Oberton Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.97 per share. 29 Aug 2024 26,080 129,996 (0%) 0% 41.0 1,068,498 Common Stock
Brandon Schnittker Div. President, GYN Surgical Sale of securities on an exchange or to another person at price $ 83.11 per share. 06 Aug 2024 476 3,735 (0%) 0% 83.1 39,559 Common Stock
Benjamin J. Cohn Principal Accounting Officer Sale of securities on an exchange or to another person at price $ 81.99 per share. 01 Aug 2024 5,093 10,476 (0%) 0% 82.0 417,570 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share. 30 Jul 2024 44,039 1,201,601 (0%) 0% 26.2 1,154,262 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jul 2024 44,039 0 - - Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan Director, Chairman, President and CEO Sale of securities on an exchange or to another person at price $ 82.32 per share. 30 Jul 2024 20,228 1,157,562 (0%) 0% 82.3 1,665,169 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Sale of securities on an exchange or to another person at price $ 81.44 per share. 30 Jul 2024 16,177 1,177,790 (0%) 0% 81.4 1,317,455 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Sale of securities on an exchange or to another person at price $ 80.60 per share. 30 Jul 2024 7,634 1,193,967 (0%) 0% 80.6 615,300 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Jul 2024 3,672 44,039 - - Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan Director, Chairman, President and CEO Sale of securities on an exchange or to another person at price $ 80.13 per share. 17 Jul 2024 3,672 1,157,562 (0%) 0% 80.1 294,223 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share. 17 Jul 2024 3,672 1,161,234 (0%) 0% 26.2 96,243 Common Stock
Christiana Stamoulis Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Jul 2024 9,039 0 - - Non-qualified Stock Option (Right to Buy)
Christiana Stamoulis Director Sale of securities on an exchange or to another person at price $ 79.50 per share. 17 Jul 2024 9,039 45,472 (0%) 0% 79.5 718,601 Common Stock
Christiana Stamoulis Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.74 per share. 17 Jul 2024 9,039 54,511 (0%) 0% 26.7 241,703 Common Stock
Brandon Schnittker Div. President, GYN Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.78 per share. 31 May 2024 67 4,211 (0%) 0% 73.8 4,943 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Gift of securities by or to the insider at price $ 0.00 per share. 23 May 2024 57,875 1,157,213 (0%) 0% 0 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Gift of securities by or to the insider at price $ 0.00 per share. 19 Apr 2024 12,000 1,215,088 (0%) 0% 0 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Gift of securities by or to the insider at price $ 0.00 per share. 19 Apr 2024 12,000 1,227,088 (0%) 0% 0 Common Stock
Scott T. Garrett Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2024 7,402 0 - - Non-qualified Stock Option (Right to Buy)
Scott T. Garrett Director Sale of securities on an exchange or to another person at price $ 75.50 per share. 14 Mar 2024 16,441 48,611 (0%) 0% 75.5 1,241,296 Common Stock
Scott T. Garrett Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.04 per share. 14 Mar 2024 7,402 65,052 (0%) 0% 36.0 266,768 Common Stock
Scott T. Garrett Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.74 per share. 14 Mar 2024 9,039 57,650 (0%) 0% 26.7 241,703 Common Stock
Scott T. Garrett Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2024 9,039 0 - - Non-qualified Stock Option (Right to Buy)
Charles J. Dockendorff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 1,572 3,037 (0%) 0% - Common Stock
Charles J. Dockendorff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 4,536 4,536 - - Non-qualified Stock Option (Right to Buy)
Charles J. Dockendorff Director Sale of securities on an exchange or to another person at price $ 76.21 per share. 07 Mar 2024 1,465 1,572 (0%) 0% 76.2 111,648 Common Stock
Scott T. Garrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 4,536 4,536 - - Non-qualified Stock Option (Right to Buy)
Scott T. Garrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 1,572 48,611 (0%) 0% - Common Stock
Sally Wellinghoff Crawford Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 1,572 132,927 (0%) 0% - Common Stock
Sally Wellinghoff Crawford Director Sale of securities on an exchange or to another person at price $ 76.40 per share. 07 Mar 2024 9,039 132,927 (0%) 0% 76.4 690,607 Common Stock
Sally Wellinghoff Crawford Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.74 per share. 07 Mar 2024 9,039 141,966 (0%) 0% 26.7 241,703 Common Stock
Sally Wellinghoff Crawford Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 4,536 4,536 - - Non-qualified Stock Option (Right to Buy)
Sally Wellinghoff Crawford Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Mar 2024 9,039 0 - - Non-qualified Stock Option (Right to Buy)
Amy A. Wendell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 1,572 20,730 (0%) 0% - Common Stock
Amy A. Wendell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 4,536 4,536 - - Non-qualified Stock Option (Right to Buy)
Stacey D. Stewart Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 1,572 3,304 (0%) 0% - Common Stock
Stacey D. Stewart Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 4,536 4,536 - - Non-qualified Stock Option (Right to Buy)
Ludwig N. Hantson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 1,572 11,092 (0%) 0% - Common Stock
Ludwig N. Hantson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 4,536 4,536 - - Non-qualified Stock Option (Right to Buy)
Christiana Stamoulis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 1,572 45,472 (0%) 0% - Common Stock
Christiana Stamoulis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 4,536 4,536 - - Non-qualified Stock Option (Right to Buy)
Nanaz Mohtashami Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 4,536 4,536 - - Non-qualified Stock Option (Right to Buy)
Nanaz Mohtashami Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 1,572 2,317 (0%) 0% - Common Stock
Oberton Karleen M. Chief Financial Officer Sale of securities on an exchange or to another person at price $ 75.00 per share. 29 Jan 2024 14,940 103,916 (0%) 0% 75 1,120,500 Common Stock
J. Dockendorff Charles Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jan 2024 7,551 0 - - Non-qualified Stock Option (Right to Buy)
J. Dockendorff Charles Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.44 per share. 02 Jan 2024 7,551 17,482 (0%) 0% 38.4 290,260 Common Stock
Charles J. Dockendorff Director Sale of securities on an exchange or to another person at price $ 72.00 per share. 02 Jan 2024 16,017 1,465 (0%) 0% 72 1,153,224 Common Stock
Dunne Peter Paul SVP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 3,554 3,554 - - Non-qualified Stock Option (Right to Buy)
Dunne Peter Paul SVP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 1,231 10,643 (0%) 0% - Common Stock
Garrett T. Scott Director Sale of securities on an exchange or to another person at price $ 68.71 per share. 11 Dec 2023 10,000 47,039 (0%) 0% 68.7 687,116 Common Stock
Jan Verstreken Group President, International Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.97 per share. 30 Jun 2023 322 78,426 (0%) 0% 81.0 26,072 Common Stock
Scott T. Garrett Director Sale of securities on an exchange or to another person at price $ 79.72 per share. 15 Jun 2023 10,000 57,039 (0%) 0% 79.7 797,240 Common Stock
Essex D. Mitchell Div. President, GYN Surgical Sale of securities on an exchange or to another person at price $ 83.73 per share. 05 May 2023 2,390 7,212 (0%) 0% 83.7 200,115 Common Stock
Charles J. Dockendorff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 1,465 6,725 (0%) 0% - Common Stock
Charles J. Dockendorff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 4,210 4,210 - - Non-qualified Stock Option (Right to Buy)
Scott T. Garrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 1,465 67,039 (0%) 0% - Common Stock
Scott T. Garrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 4,210 4,210 - - Non-qualified Stock Option (Right to Buy)
Sally Wellinghoff Crawford Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 1,465 131,355 (0%) 0% - Common Stock
Sally Wellinghoff Crawford Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 4,210 4,210 - - Non-qualified Stock Option (Right to Buy)
Amy A. Wendell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 1,465 19,158 (0%) 0% - Common Stock
Amy A. Wendell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 4,210 4,210 - - Non-qualified Stock Option (Right to Buy)
Stacey D. Stewart Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 1,465 1,732 (0%) 0% - Common Stock
Stacey D. Stewart Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 4,210 4,210 - - Non-qualified Stock Option (Right to Buy)
Ludwig N. Hantson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 4,210 4,210 - - Non-qualified Stock Option (Right to Buy)
Ludwig N. Hantson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 1,465 9,520 (0%) 0% - Common Stock
Christiana Stamoulis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 4,210 4,210 - - Non-qualified Stock Option (Right to Buy)
Christiana Stamoulis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 1,465 43,900 (0%) 0% - Common Stock
Namal Nawana Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 4,210 4,210 - - Non-qualified Stock Option (Right to Buy)
Namal Nawana Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 1,465 18,221 (0%) 0% - Common Stock
Erik Anderson Div. Pres., Breast & Skeletal Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.06 per share. 01 Mar 2023 381 10,311 (0%) 0% 79.1 30,122 Common Stock
Charles J. Dockendorff Director Gift of securities by or to the insider at price $ 0.00 per share. 07 Feb 2023 1,336 0 (0%) 0% 0 Common Stock
Benjamin J. Cohn Principal Accounting Officer Sale of securities on an exchange or to another person at price $ 85.28 per share. 07 Feb 2023 9,128 14,298 (0%) 0% 85.3 778,445 Common Stock
Benjamin J. Cohn Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Feb 2023 9,128 0 - - Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.97 per share. 07 Feb 2023 9,128 23,426 (0%) 0% 41.0 373,974 Common Stock
Stacey D. Stewart Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 267 267 (0%) 0% - Common Stock
Stacey D. Stewart Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 768 768 - - Non-qualified Stock Option (Right to Buy)
John M. Griffin General Counsel 05 Dec 2022 2,989 165,955 (0%) 0% 0 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Sale of securities on an exchange or to another person at price $ 76.02 per share. 30 Nov 2022 12,501 2,313,970 (0%) 0% 76.0 950,326 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Sale of securities on an exchange or to another person at price $ 75.43 per share. 30 Nov 2022 20,999 2,326,471 (0%) 0% 75.4 1,584,039 Common Stock
Kevin R. Thornal Group Pres, Global Diagnostics Sale of securities on an exchange or to another person at price $ 75.37 per share. 15 Nov 2022 6,628 62,368 (0%) 0% 75.4 499,552 Common Stock
Kevin R. Thornal Group Pres, Global Diagnostics Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Nov 2022 12,490 0 - - Non-qualified Stock Option (Right to Buy)
Kevin R. Thornal Group Pres, Global Diagnostics Sale of securities on an exchange or to another person at price $ 75.30 per share. 15 Nov 2022 12,490 62,368 (0%) 0% 75.3 940,509 Common Stock
Kevin R. Thornal Group Pres, Global Diagnostics Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.85 per share. 15 Nov 2022 12,490 74,858 (0%) 0% 40.9 510,217 Common Stock
John M. Griffin General Counsel 14 Nov 2022 23,634 172,212 (0%) 0% 76.1 1,797,909 Common Stock
John M. Griffin General Counsel 14 Nov 2022 26,902 0 - - Non-qualified Stock Option (Right to Buy)
John M. Griffin General Counsel 14 Nov 2022 3,268 168,944 (0%) 0% 76.5 249,979 Common Stock
John M. Griffin General Counsel 14 Nov 2022 26,902 195,846 (0%) 0% 40.9 1,098,947 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share. 09 Nov 2022 95,422 2,539,247 (0%) 0% 26.2 2,501,011 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share. 09 Nov 2022 5,776 2,486,825 (0%) 0% 72.1 416,507 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Nov 2022 95,422 95,422 - - Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.93 per share. 09 Nov 2022 96,355 2,347,470 (0%) 0% 75.9 7,316,235 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Sale of securities on an exchange or to another person at price $ 75.94 per share. 09 Nov 2022 42,893 2,443,825 (0%) 0% 75.9 3,257,294 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Sale of securities on an exchange or to another person at price $ 75.57 per share. 09 Nov 2022 52,529 2,486,718 (0%) 0% 75.6 3,969,564 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Sale of securities on an exchange or to another person at price $ 75.64 per share. 09 Nov 2022 43,000 2,443,825 (0%) 0% 75.6 3,252,520 Common Stock
Karleen M. Oberton Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share. 09 Nov 2022 680 133,008 (0%) 0% 72.1 49,035 Common Stock
Karleen M. Oberton Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.93 per share. 09 Nov 2022 15,145 117,863 (0%) 0% 75.9 1,149,960 Common Stock
John M. Griffin General Counsel 09 Nov 2022 13,141 168,944 (0%) 0% 75.9 997,796 Common Stock
John M. Griffin General Counsel 09 Nov 2022 609 182,085 (0%) 0% 72.1 43,915 Common Stock
Benjamin J. Cohn Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.93 per share. 09 Nov 2022 322 14,207 (0%) 0% 75.9 24,449 Common Stock
Benjamin J. Cohn Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share. 09 Nov 2022 215 14,529 (0%) 0% 72.1 15,504 Common Stock
Kevin R. Thornal Group Pres, Global Diagnostics Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.93 per share. 09 Nov 2022 8,780 68,996 (0%) 0% 75.9 666,665 Common Stock
Kevin R. Thornal Group Pres, Global Diagnostics Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share. 09 Nov 2022 591 77,776 (0%) 0% 72.1 42,617 Common Stock
Essex D. Mitchell Div. President, GYN Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share. 09 Nov 2022 201 9,707 (0%) 0% 72.1 14,494 Common Stock
Essex D. Mitchell Div. President, GYN Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.93 per share. 09 Nov 2022 252 9,455 (0%) 0% 75.9 19,134 Common Stock
Erik Anderson Div. Pres., Breast & Skeletal Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share. 09 Nov 2022 131 10,692 (0%) 0% 72.1 9,446 Common Stock
Jan Verstreken Group President, International Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share. 09 Nov 2022 135 80,663 (0%) 0% 72.1 9,735 Common Stock
Jan Verstreken Group President, International Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.93 per share. 09 Nov 2022 1,915 78,748 (0%) 0% 75.9 145,406 Common Stock
Elisabeth A. Hellmann SVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share. 09 Nov 2022 194 10,479 (0%) 0% 72.1 13,989 Common Stock
Elisabeth A. Hellmann SVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.93 per share. 09 Nov 2022 285 10,194 (0%) 0% 75.9 21,640 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.71 per share. 07 Nov 2022 4,052 2,492,601 (0%) 0% 73.7 298,673 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2022 106,300 106,300 - - Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2022 36,987 2,496,653 (0%) 0% - Common Stock
Karleen M. Oberton Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2022 7,565 134,376 (0%) 0% - Common Stock
Karleen M. Oberton Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2022 21,743 21,743 - - Non-qualified Stock Option (Right to Buy)
Karleen M. Oberton Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.71 per share. 07 Nov 2022 688 133,688 (0%) 0% 73.7 50,712 Common Stock
John M. Griffin General Counsel 07 Nov 2022 17,394 17,394 - - Non-qualified Stock Option (Right to Buy)
John M. Griffin General Counsel 07 Nov 2022 6,052 183,296 (0%) 0% - Common Stock
John M. Griffin General Counsel 07 Nov 2022 602 182,694 (0%) 0% 73.7 44,373 Common Stock
Benjamin J. Cohn Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.71 per share. 07 Nov 2022 207 14,744 (0%) 0% 73.7 15,258 Common Stock
Benjamin J. Cohn Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2022 1,176 14,951 (0%) 0% - Common Stock
Benjamin J. Cohn Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2022 3,382 3,382 - - Non-qualified Stock Option (Right to Buy)
Kevin R. Thornal Group Pres, Global Diagnostics Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2022 19,327 19,327 - - Non-qualified Stock Option (Right to Buy)
Kevin R. Thornal Group Pres, Global Diagnostics Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.71 per share. 07 Nov 2022 709 78,367 (0%) 0% 73.7 52,260 Common Stock
Kevin R. Thornal Group Pres, Global Diagnostics Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2022 6,724 79,076 (0%) 0% - Common Stock
Essex D. Mitchell Div. President, GYN Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.71 per share. 07 Nov 2022 322 9,908 (0%) 0% 73.7 23,735 Common Stock
Essex D. Mitchell Div. President, GYN Surgical Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2022 4,034 10,230 (0%) 0% - Common Stock
Essex D. Mitchell Div. President, GYN Surgical Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2022 11,596 11,596 - - Non-qualified Stock Option (Right to Buy)
Erik Anderson Div. Pres., Breast & Skeletal Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.71 per share. 07 Nov 2022 126 10,823 (0%) 0% 73.7 9,287 Common Stock
Erik Anderson Div. Pres., Breast & Skeletal Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2022 9,663 9,663 - - Non-qualified Stock Option (Right to Buy)
Erik Anderson Div. Pres., Breast & Skeletal Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2022 3,362 10,949 (0%) 0% - Common Stock
Jan Verstreken Group President, International Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2022 6,724 80,992 (0%) 0% - Common Stock
Jan Verstreken Group President, International Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2022 19,327 19,327 - - Non-qualified Stock Option (Right to Buy)
Jan Verstreken Group President, International Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.71 per share. 07 Nov 2022 194 80,798 (0%) 0% 73.7 14,300 Common Stock
Elisabeth A. Hellmann SVP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2022 6,764 6,764 - - Non-qualified Stock Option (Right to Buy)
Elisabeth A. Hellmann SVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.71 per share. 07 Nov 2022 243 10,673 (0%) 0% 73.7 17,912 Common Stock
Elisabeth A. Hellmann SVP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2022 2,353 10,916 (0%) 0% - Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Nov 2022 103,447 2,459,666 (0%) 0% - Common Stock
Karleen M. Oberton Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Nov 2022 7,389 0 - - Non-qualified Stock Option (Right to Buy)
Karleen M. Oberton Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Nov 2022 20,872 126,811 (0%) 0% - Common Stock
Karleen M. Oberton Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.64 per share. 01 Nov 2022 7,389 141,356 (0%) 0% 37.6 278,122 Common Stock
Karleen M. Oberton Chief Financial Officer Sale of securities on an exchange or to another person at price $ 72.50 per share. 01 Nov 2022 14,545 126,811 (0%) 0% 72.5 1,054,513 Common Stock
Karleen M. Oberton Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Nov 2022 7,156 0 - - Non-qualified Stock Option (Right to Buy)
Karleen M. Oberton Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.96 per share. 01 Nov 2022 7,156 133,967 (0%) 0% 40.0 285,954 Common Stock
John M. Griffin General Counsel 01 Nov 2022 19,642 177,244 (0%) 0% - Common Stock
Kevin R. Thornal Div. President, Diagnostics Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Nov 2022 12,277 72,352 (0%) 0% - Common Stock
Jan Verstreken Group President, International Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Nov 2022 10,436 74,268 (0%) 0% - Common Stock
Jan Verstreken Group President, International Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.14 per share. 01 Jul 2022 359 63,832 (0%) 0% 70.1 25,180 Common Stock
Benjamin J. Cohn Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2022 3,844 0 - - Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn Principal Accounting Officer Sale of securities on an exchange or to another person at price $ 78.75 per share. 17 May 2022 3,844 13,532 (0%) 0% 78.8 302,730 Common Stock
Benjamin J. Cohn Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.85 per share. 17 May 2022 3,844 17,376 (0%) 0% 40.8 157,027 Common Stock
Jan Verstreken Group President, International Sale of securities on an exchange or to another person at price $ 78.80 per share. 17 May 2022 6,500 64,191 (0%) 0% 78.8 512,168 Common Stock
Benjamin J. Cohn Principal Accounting Officer Sale of securities on an exchange or to another person at price $ 75.49 per share. 13 May 2022 3,210 13,532 (0%) 0% 75.5 242,333 Common Stock
Benjamin J. Cohn Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.64 per share. 13 May 2022 3,210 16,742 (0%) 0% 37.6 120,824 Common Stock
Benjamin J. Cohn Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 May 2022 3,842 3,844 - - Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 May 2022 3,210 0 - - Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn Principal Accounting Officer Sale of securities on an exchange or to another person at price $ 75.49 per share. 13 May 2022 3,842 13,532 (0%) 0% 75.5 290,033 Common Stock
Benjamin J. Cohn Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.85 per share. 13 May 2022 3,842 17,374 (0%) 0% 40.9 156,946 Common Stock
Benjamin J. Cohn Principal Accounting Officer Sale of securities on an exchange or to another person at price $ 74.18 per share. 03 May 2022 2,178 13,532 (0%) 0% 74.2 161,564 Common Stock
Charles J. Dockendorff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 1,565 5,260 (0%) 0% - Common Stock
Charles J. Dockendorff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 5,293 5,293 - - Non-qualified Stock Option (Right to Buy)
Scott T. Garrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 5,293 5,293 - - Non-qualified Stock Option (Right to Buy)
Scott T. Garrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 1,565 65,574 (0%) 0% - Common Stock
Sally Wellinghoff Crawford Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 5,293 5,293 - - Non-qualified Stock Option (Right to Buy)
Sally Wellinghoff Crawford Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 1,565 129,890 (0%) 0% - Common Stock
Amy A. Wendell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 5,293 5,293 - - Non-qualified Stock Option (Right to Buy)
Amy A. Wendell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 1,565 17,693 (0%) 0% - Common Stock
Ludwig N. Hantson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 5,293 5,293 - - Non-qualified Stock Option (Right to Buy)
Ludwig N. Hantson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 1,565 8,055 (0%) 0% - Common Stock
Christiana Stamoulis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 1,565 42,435 (0%) 0% - Common Stock
Christiana Stamoulis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 5,293 5,293 - - Non-qualified Stock Option (Right to Buy)
Namal Nawana Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 1,565 16,756 (0%) 0% - Common Stock
Namal Nawana Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 5,293 5,293 - - Non-qualified Stock Option (Right to Buy)
Sean S. Daugherty Group President, BSH & Surg. Sale of securities on an exchange or to another person at price $ 71.14 per share. 24 Feb 2022 2,179 49,091 (0%) 0% 71.1 155,016 Common Stock
Benjamin J. Cohn Principal Accounting Officer Sale of securities on an exchange or to another person at price $ 75.79 per share. 19 Nov 2021 2,570 15,604 (0%) 0% 75.8 194,791 Common Stock
Jan Verstreken Group President, International Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.54 per share. 12 Nov 2021 2,027 70,691 (0%) 0% 73.5 149,066 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.61 per share. 11 Nov 2021 7,345 2,447,670 (0%) 0% 72.6 533,320 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.54 per share. 11 Nov 2021 91,777 2,355,893 (0%) 0% 73.5 6,749,281 Common Stock
Karleen M. Oberton Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.61 per share. 11 Nov 2021 912 105,939 (0%) 0% 72.6 66,220 Common Stock
John M. Griffin General Counsel 11 Nov 2021 13,184 157,602 (0%) 0% 73.5 969,551 Common Stock
John M. Griffin General Counsel 11 Nov 2021 1,297 170,786 (0%) 0% 72.6 94,175 Common Stock
Benjamin J. Cohn Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.54 per share. 11 Nov 2021 293 18,174 (0%) 0% 73.5 21,547 Common Stock
Benjamin J. Cohn Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.61 per share. 11 Nov 2021 322 18,467 (0%) 0% 72.6 23,380 Common Stock
Kevin R. Thornal Div. President, Diagnostics Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.54 per share. 11 Nov 2021 6,833 60,075 (0%) 0% 73.5 502,499 Common Stock
Kevin R. Thornal Div. President, Diagnostics Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.61 per share. 11 Nov 2021 632 66,908 (0%) 0% 72.6 45,890 Common Stock
Sean S. Daugherty Group President, BSH & Surg. Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.54 per share. 11 Nov 2021 6,406 51,270 (0%) 0% 73.5 471,097 Common Stock
Sean S. Daugherty Group President, BSH & Surg. Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.61 per share. 11 Nov 2021 556 57,676 (0%) 0% 72.6 40,371 Common Stock
Elisabeth A. Hellmann SVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.54 per share. 11 Nov 2021 282 8,292 (0%) 0% 73.5 20,738 Common Stock
Elisabeth A. Hellmann SVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.61 per share. 11 Nov 2021 285 8,574 (0%) 0% 72.6 20,694 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.26 per share. 08 Nov 2021 4,173 2,455,015 (0%) 0% 71.3 297,368 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2021 118,877 118,877 - - Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2021 35,146 2,459,188 (0%) 0% - Common Stock
Karleen M. Oberton Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2021 7,029 107,531 (0%) 0% - Common Stock
Karleen M. Oberton Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.26 per share. 08 Nov 2021 680 106,851 (0%) 0% 71.3 48,457 Common Stock
Karleen M. Oberton Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2021 23,775 23,775 - - Non-qualified Stock Option (Right to Buy)
John M. Griffin General Counsel 08 Nov 2021 20,803 20,803 - - Non-qualified Stock Option (Right to Buy)
John M. Griffin General Counsel 08 Nov 2021 6,150 173,002 (0%) 0% - Common Stock
John M. Griffin General Counsel 08 Nov 2021 919 172,083 (0%) 0% 71.3 65,488 Common Stock
Benjamin J. Cohn Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2021 7,132 7,132 - - Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2021 2,108 19,004 (0%) 0% - Common Stock
Benjamin J. Cohn Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.26 per share. 08 Nov 2021 215 18,789 (0%) 0% 71.3 15,321 Common Stock
Kevin R. Thornal Div. President, Diagnostics Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2021 20,803 20,803 - - Non-qualified Stock Option (Right to Buy)
Kevin R. Thornal Div. President, Diagnostics Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2021 6,150 68,130 (0%) 0% - Common Stock
Kevin R. Thornal Div. President, Diagnostics Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.26 per share. 08 Nov 2021 590 67,540 (0%) 0% 71.3 42,043 Common Stock
Sean S. Daugherty Group President, BSH & Surg. Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2021 5,272 58,701 (0%) 0% - Common Stock
Sean S. Daugherty Group President, BSH & Surg. Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2021 17,831 17,831 - - Non-qualified Stock Option (Right to Buy)
Sean S. Daugherty Group President, BSH & Surg. Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.26 per share. 08 Nov 2021 469 58,232 (0%) 0% 71.3 33,421 Common Stock
Jan Verstreken Group President, International Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2021 5,272 73,028 (0%) 0% - Common Stock
Jan Verstreken Group President, International Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2021 17,831 17,831 - - Non-qualified Stock Option (Right to Buy)
Jan Verstreken Group President, International Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.26 per share. 08 Nov 2021 310 72,718 (0%) 0% 71.3 22,091 Common Stock
Elisabeth A. Hellmann SVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.26 per share. 08 Nov 2021 194 8,859 (0%) 0% 71.3 13,824 Common Stock
Elisabeth A. Hellmann SVP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2021 2,108 9,053 (0%) 0% - Common Stock
Elisabeth A. Hellmann SVP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2021 7,132 7,132 - - Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Nov 2021 240,732 2,424,042 (0%) 0% - Common Stock
Karleen M. Oberton Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Nov 2021 43,424 100,502 (0%) 0% - Common Stock
John M. Griffin General Counsel 01 Nov 2021 43,252 166,852 (0%) 0% - Common Stock
Kevin R. Thornal Div. President, Diagnostics Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Nov 2021 28,764 61,980 (0%) 0% - Common Stock
Sean S. Daugherty Group President, BSH & Surg. Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Nov 2021 26,816 53,429 (0%) 0% - Common Stock
Jan Verstreken Group President, International Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Nov 2021 23,087 67,756 (0%) 0% - Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Gift of securities by or to the insider at price $ 0.00 per share. 25 Sep 2021 5,250 2,182,967 (0%) 0% 0 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Gift of securities by or to the insider at price $ 0.00 per share. 25 Sep 2021 15,000 2,188,217 (0%) 0% 0 Common Stock
Elisabeth A. Hellmann SVP, Human Resources Gift of securities by or to the insider at price $ 0.00 per share. 25 Sep 2021 441 6,945 (0%) 0% 0 Common Stock
Benjamin J. Cohn Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.64 per share. 10 Aug 2021 5,000 21,896 (0%) 0% 37.6 188,200 Common Stock
Benjamin J. Cohn Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Aug 2021 5,000 3,210 - - Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn Principal Accounting Officer Sale of securities on an exchange or to another person at price $ 77.48 per share. 10 Aug 2021 5,000 16,896 (0%) 0% 77.5 387,425 Common Stock
John M. Griffin General Counsel 09 Aug 2021 26,683 150,283 (0%) 0% 37.6 1,004,348 Common Stock
John M. Griffin General Counsel 09 Aug 2021 26,683 0 - - Non-qualified Stock Option (Right to Buy)
John M. Griffin General Counsel 09 Aug 2021 26,683 123,600 (0%) 0% 75.6 2,017,768 Common Stock
Jan Verstreken Group President, International Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.99 per share. 01 Jul 2021 351 44,669 (0%) 0% 68.0 23,864 Common Stock
Sean S. Daugherty Group President, BSH & Surg. Sale of securities on an exchange or to another person at price $ 65.02 per share. 10 May 2021 4,001 26,613 (0%) 0% 65.0 260,149 Common Stock
Charles J. Dockendorff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2021 5,055 5,055 - - Non-qualified Stock Option (Right to Buy)
Charles J. Dockendorff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2021 1,478 3,695 (0%) 0% - Common Stock
Scott T. Garrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2021 1,478 64,009 (0%) 0% - Common Stock
Scott T. Garrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2021 5,055 5,055 - - Non-qualified Stock Option (Right to Buy)
Sally Wellinghoff Crawford Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2021 1,478 128,325 (0%) 0% - Common Stock
Sally Wellinghoff Crawford Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2021 5,055 5,055 - - Non-qualified Stock Option (Right to Buy)
Amy A. Wendell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2021 1,478 16,128 (0%) 0% - Common Stock
Amy A. Wendell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2021 5,055 5,055 - - Non-qualified Stock Option (Right to Buy)
Ludwig N. Hantson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2021 1,478 6,490 (0%) 0% - Common Stock
Ludwig N. Hantson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2021 5,055 5,055 - - Non-qualified Stock Option (Right to Buy)
Christiana Stamoulis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2021 1,478 40,870 (0%) 0% - Common Stock
Christiana Stamoulis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2021 5,055 5,055 - - Non-qualified Stock Option (Right to Buy)
Namal Nawana Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2021 5,055 5,055 - - Non-qualified Stock Option (Right to Buy)
Namal Nawana Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2021 1,478 15,191 (0%) 0% - Common Stock
Allison P. Bebo SVP, Human Resources Sale of securities on an exchange or to another person at price $ 84.06 per share. 05 Feb 2021 6,100 35,680 (0%) 0% 84.1 512,778 Common Stock
Benjamin J. Cohn Principal Accounting Officer Sale of securities on an exchange or to another person at price $ 84.31 per share. 04 Feb 2021 8,396 16,652 (0%) 0% 84.3 707,867 Common Stock
Benjamin J. Cohn Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Feb 2021 8,396 0 - - Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.96 per share. 04 Feb 2021 8,396 25,048 (0%) 0% 40.0 335,504 Common Stock
Benjamin J. Cohn Principal Accounting Officer Sale of securities on an exchange or to another person at price $ 73.64 per share. 10 Dec 2020 1,477 16,575 (0%) 0% 73.6 108,759 Common Stock
Kevin R. Thornal Div. President, Diagnostics Sale of securities on an exchange or to another person at price $ 74.00 per share. 10 Dec 2020 7,633 33,216 (0%) 0% 74.0 564,804 Common Stock
Kevin R. Thornal Div. President, Diagnostics Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2020 7,633 0 - - Non-qualified Stock Option (Right to Buy)
Kevin R. Thornal Div. President, Diagnostics Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2020 9,236 0 - - Non-qualified Stock Option (Right to Buy)
Kevin R. Thornal Div. President, Diagnostics Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.64 per share. 10 Dec 2020 9,236 42,452 (0%) 0% 37.6 347,643 Common Stock
Kevin R. Thornal Div. President, Diagnostics Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.96 per share. 10 Dec 2020 7,633 40,849 (0%) 0% 40.0 305,015 Common Stock
Kevin R. Thornal Div. President, Diagnostics Sale of securities on an exchange or to another person at price $ 73.99 per share. 10 Dec 2020 9,236 33,216 (0%) 0% 74.0 683,409 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.63 per share. 01 Dec 2020 439,919 2,203,217 (0%) 0% 69.6 30,631,560 Common Stock
Karleen M. Oberton Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.63 per share. 01 Dec 2020 317 57,078 (0%) 0% 69.6 22,073 Common Stock
John M. Griffin General Counsel 01 Dec 2020 10,886 123,600 (0%) 0% 69.6 757,992 Common Stock
Allison P. Bebo SVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.63 per share. 01 Dec 2020 5,763 41,780 (0%) 0% 69.6 401,278 Common Stock
Benjamin J. Cohn Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.63 per share. 01 Dec 2020 240 18,052 (0%) 0% 69.6 16,711 Common Stock
Kevin R. Thornal Div. President, Diagnostics Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.63 per share. 01 Dec 2020 5,450 33,216 (0%) 0% 69.6 379,484 Common Stock
Sean S. Daugherty Group President, BSH & Surg. Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.63 per share. 01 Dec 2020 4,604 30,614 (0%) 0% 69.6 320,577 Common Stock
Jan Verstreken Group President, International Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.63 per share. 01 Dec 2020 1,337 45,020 (0%) 0% 69.6 93,095 Common Stock
John M. Griffin General Counsel 18 Nov 2020 11,321 146,065 (0%) 0% 70.8 801,482 Common Stock
John M. Griffin General Counsel 18 Nov 2020 22,900 0 - - Non-qualified Stock Option (Right to Buy)
John M. Griffin General Counsel 18 Nov 2020 11,579 134,486 (0%) 0% 71.4 826,208 Common Stock
John M. Griffin General Counsel 18 Nov 2020 22,900 157,386 (0%) 0% 40.0 915,084 Common Stock
Benjamin J. Cohn Principal Accounting Officer Sale of securities on an exchange or to another person at price $ 72.58 per share. 17 Nov 2020 5,000 18,292 (0%) 0% 72.6 362,900 Common Stock
Benjamin J. Cohn Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Nov 2020 5,000 0 - - Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share. 17 Nov 2020 5,000 23,292 (0%) 0% 26.2 131,050 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.20 per share. 12 Nov 2020 8,179 2,643,136 (1%) 0% 70.2 574,166 Common Stock
John M. Griffin General Counsel 12 Nov 2020 896 134,486 (0%) 0% 70.2 62,899 Common Stock
Allison P. Bebo SVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.20 per share. 12 Nov 2020 463 47,543 (0%) 0% 70.2 32,503 Common Stock
Benjamin J. Cohn Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Nov 2020 6,542 5,000 - - Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.20 per share. 12 Nov 2020 293 18,292 (0%) 0% 70.2 20,569 Common Stock
Benjamin J. Cohn Principal Accounting Officer Sale of securities on an exchange or to another person at price $ 70.60 per share. 12 Nov 2020 6,542 18,585 (0%) 0% 70.6 461,846 Common Stock
Benjamin J. Cohn Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share. 12 Nov 2020 6,542 25,127 (0%) 0% 26.2 171,466 Common Stock
Kevin R. Thornal Div. President, Diagnostics Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.20 per share. 12 Nov 2020 598 38,666 (0%) 0% 70.2 41,980 Common Stock
Sean S. Daugherty Group President, BSH & Surg. Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.20 per share. 12 Nov 2020 554 35,218 (0%) 0% 70.2 38,891 Common Stock
Jan Verstreken Group President, International Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.20 per share. 12 Nov 2020 46 46,357 (0%) 0% 70.2 3,229 Common Stock
Scott T. Garrett Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.35 per share. 09 Nov 2020 11,146 62,531 (0%) 0% 22.3 249,113 Common Stock
Scott T. Garrett Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Nov 2020 11,146 0 - - Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.84 per share. 09 Nov 2020 7,633 2,651,315 (1%) 0% 69.8 533,089 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Nov 2020 123,801 123,801 - - Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Nov 2020 36,199 2,658,948 (1%) 0% - Common Stock
Karleen M. Oberton Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.84 per share. 09 Nov 2020 912 57,395 (0%) 0% 69.8 63,694 Common Stock
Karleen M. Oberton Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Nov 2020 6,949 58,307 (0%) 0% - Common Stock
Karleen M. Oberton Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Nov 2020 23,767 23,767 - - Non-qualified Stock Option (Right to Buy)
John M. Griffin General Counsel 09 Nov 2020 21,265 21,265 - - Non-qualified Stock Option (Right to Buy)
John M. Griffin General Counsel 09 Nov 2020 858 135,382 (0%) 0% 69.8 59,923 Common Stock
John M. Griffin General Counsel 09 Nov 2020 6,217 136,240 (0%) 0% - Common Stock
Allison P. Bebo SVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.84 per share. 09 Nov 2020 471 48,006 (0%) 0% 69.8 32,895 Common Stock
Allison P. Bebo SVP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Nov 2020 3,291 48,477 (0%) 0% - Common Stock
Allison P. Bebo SVP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Nov 2020 11,258 11,258 - - Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.84 per share. 09 Nov 2020 322 18,585 (0%) 0% 69.8 22,488 Common Stock
Benjamin J. Cohn Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Nov 2020 7,505 7,505 - - Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Nov 2020 2,194 18,907 (0%) 0% - Common Stock
Kevin R. Thornal Div. President, Diagnostics Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Nov 2020 5,120 39,896 (0%) 0% - Common Stock
Kevin R. Thornal Div. President, Diagnostics Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Nov 2020 17,512 17,512 - - Non-qualified Stock Option (Right to Buy)
Kevin R. Thornal Div. President, Diagnostics Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.84 per share. 09 Nov 2020 632 39,264 (0%) 0% 69.8 44,139 Common Stock
Sean S. Daugherty Group President, BSH & Surg. Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.84 per share. 09 Nov 2020 556 35,772 (0%) 0% 69.8 38,831 Common Stock
Sean S. Daugherty Group President, BSH & Surg. Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Nov 2020 4,389 36,328 (0%) 0% - Common Stock
Sean S. Daugherty Group President, BSH & Surg. Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Nov 2020 15,010 15,010 - - Non-qualified Stock Option (Right to Buy)
Jan Verstreken Group President, International Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Nov 2020 12,509 12,509 - - Non-qualified Stock Option (Right to Buy)
Jan Verstreken Group President, International Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Nov 2020 3,657 46,435 (0%) 0% - Common Stock
Jan Verstreken Group President, International Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.84 per share. 09 Nov 2020 32 46,403 (0%) 0% 69.8 2,235 Common Stock
Christiana Stamoulis Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Nov 2020 11,146 0 - - Non-qualified Stock Option (Right to Buy)
Christiana Stamoulis Director Sale of securities on an exchange or to another person at price $ 74.00 per share. 04 Nov 2020 11,146 39,392 (0%) 0% 74 824,804 Common Stock
Christiana Stamoulis Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.35 per share. 04 Nov 2020 11,146 50,538 (0%) 0% 22.3 249,113 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2020 900,307 2,622,749 (0%) 0% - Common Stock
Karleen M. Oberton Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2020 16,941 51,358 (0%) 0% - Common Stock
John M. Griffin General Counsel 02 Nov 2020 34,716 130,023 (0%) 0% - Common Stock
Allison P. Bebo SVP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2020 16,797 45,186 (0%) 0% - Common Stock
Kevin R. Thornal Div. President, Diagnostics Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2020 17,750 34,776 (0%) 0% - Common Stock
Sean S. Daugherty Group President, BSH & Surg. Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2020 17,432 31,939 (0%) 0% - Common Stock
Jan Verstreken Group President, International Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2020 16,797 42,778 (0%) 0% - Common Stock
Karleen M. Oberton Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share. 21 Sep 2020 15,000 43,956 (0%) 0% 26.2 393,150 Common Stock
Karleen M. Oberton Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Sep 2020 5,461 0 - - Non-qualified Stock Option (Right to Buy)
Karleen M. Oberton Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Sep 2020 15,000 5,461 - - Non-qualified Stock Option (Right to Buy)
Karleen M. Oberton Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share. 21 Sep 2020 5,461 34,417 (0%) 0% 26.2 143,133 Common Stock
Karleen M. Oberton Chief Financial Officer Sale of securities on an exchange or to another person at price $ 62.50 per share. 21 Sep 2020 15,000 28,956 (0%) 0% 62.5 937,500 Common Stock
Benjamin J. Cohn Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.82 per share. 03 Aug 2020 2,986 19,699 (0%) 0% 23.8 71,127 Common Stock
Benjamin J. Cohn Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Aug 2020 2,986 0 - - Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn Principal Accounting Officer Sale of securities on an exchange or to another person at price $ 71.23 per share. 03 Aug 2020 2,617 16,713 (0%) 0% 71.2 186,409 Common Stock
Benjamin J. Cohn Principal Accounting Officer Sale of securities on an exchange or to another person at price $ 71.22 per share. 03 Aug 2020 369 19,330 (0%) 0% 71.2 26,280 Common Stock
Benjamin J. Cohn Principal Accounting Officer Sale of securities on an exchange or to another person at price $ 71.27 per share. 03 Aug 2020 1,938 16,713 (0%) 0% 71.3 138,121 Common Stock
Peter J. Valenti Division Pres., Breast Health Sale of securities on an exchange or to another person at price $ 54.07 per share. 30 Jun 2020 10,493 59,991 (0%) 0% 54.1 567,357 Common Stock
Peter J. Valenti Division Pres., Breast Health Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2020 10,493 0 - - Non-qualified Stock Option (Right to Buy)
Peter J. Valenti Division Pres., Breast Health Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share. 30 Jun 2020 10,493 70,484 (0%) 0% 26.2 275,022 Common Stock
Sally W. Crawford Director Sale of securities on an exchange or to another person at price $ 51.99 per share. 22 May 2020 31,950 126,847 (0%) 0% 52.0 1,661,081 Common Stock
Peter J. Valenti Division Pres., Breast Health Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2020 10,493 10,493 - - Non-qualified Stock Option (Right to Buy)
Peter J. Valenti Division Pres., Breast Health Sale of securities on an exchange or to another person at price $ 51.82 per share. 22 May 2020 10,493 59,991 (0%) 0% 51.8 543,779 Common Stock
Peter J. Valenti Division Pres., Breast Health Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share. 22 May 2020 10,493 70,484 (0%) 0% 26.2 275,022 Common Stock
Kevin R. Thornal Div. President, Diagnostics Sale of securities on an exchange or to another person at price $ 51.51 per share. 15 May 2020 13,888 17,026 (0%) 0% 51.5 715,426 Common Stock
Kevin R. Thornal Div. President, Diagnostics Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 May 2020 13,888 0 - - Non-qualified Stock Option (Right to Buy)
Kevin R. Thornal Div. President, Diagnostics Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.01 per share. 15 May 2020 13,888 30,914 (0%) 0% 26.0 361,227 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Sale of securities on an exchange or to another person at price $ 50.97 per share. 13 May 2020 190,996 1,722,442 (0%) 0% 51.0 9,735,257 Common Stock
Stephen P. Macmillan Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 May 2020 215,996 0 - - Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.29 per share. 13 May 2020 215,996 1,913,438 (0%) 0% 22.3 4,814,551 Common Stock
Scott T. Garrett Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 May 2020 24,204 0 - - Non-qualified Stock Option (Right to Buy)
Scott T. Garrett Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.34 per share. 01 May 2020 24,204 51,385 (0%) 0% 20.3 492,309 Common Stock
John M. Griffin General Counsel 28 Apr 2020 2,773 0 - - Non-qualified Stock Option (Right to Buy)
John M. Griffin General Counsel 28 Apr 2020 2,133 0 - - Non-qualified Stock Option (Right to Buy)
John M. Griffin General Counsel 28 Apr 2020 2,133 95,307 (0%) 0% 50 106,650 Common Stock
John M. Griffin General Counsel 28 Apr 2020 2,133 97,440 (0%) 0% 32.4 69,067 Common Stock
John M. Griffin General Counsel 28 Apr 2020 2,773 95,307 (0%) 0% 50 138,650 Common Stock
John M. Griffin General Counsel 28 Apr 2020 2,773 98,080 (0%) 0% 32.4 89,790 Common Stock
Sally W. Crawford Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2020 11,146 0 - - Non-qualified Stock Option (Right to Buy)
Sally W. Crawford Director Sale of securities on an exchange or to another person at price $ 44.29 per share. 09 Mar 2020 7,846 158,797 (0%) 0% 44.3 347,523 Common Stock
Sally W. Crawford Director Sale of securities on an exchange or to another person at price $ 43.57 per share. 09 Mar 2020 3,300 166,643 (0%) 0% 43.6 143,794 Common Stock
Sally W. Crawford Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.35 per share. 09 Mar 2020 11,146 169,943 (0%) 0% 22.3 249,113 Common Stock
Charles J. Dockendorff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2020 7,322 7,322 - - Non-qualified Stock Option (Right to Buy)
Charles J. Dockendorff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2020 2,217 22,129 (0%) 0% - Common Stock
Scott T. Garrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2020 2,217 27,181 (0%) 0% - Common Stock
Scott T. Garrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2020 7,322 7,322 - - Non-qualified Stock Option (Right to Buy)
Sally W. Crawford Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2020 2,217 158,797 (0%) 0% - Common Stock
Sally W. Crawford Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2020 7,322 7,322 - - Non-qualified Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters